CLISTERAN

This brand name is authorized in Spain, Malta

Active ingredients

The drug CLISTERAN contains a combination of these active pharmaceutical ingredients (APIs):

1 Trisodium citrate UNII 1Q73Q2JULR - SODIUM CITRATE, UNSPECIFIED FORM
Sodium citrate has no relevant pharmacodynamic activity other than that caused by its alkalinity (e.g. its gastric acid neutralising capacity). Sodium citrate is a non-particulate antacid for use by mouth to prior to general anaesthesia for caesarean section. Read about Sodium citrate
2 Sodium lauryl sulphoacetate UNII D0Y70F2B9J - SODIUM LAURYL SULFOACETATE
Read about Sodium lauryl sulphoacetate

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
A06AG11	Sodium lauryl sulfoacetate, incl. combinations	A Alimentary tract and metabolism → A06 Laxatives → A06A Laxatives → A06AG Enemas
Discover more medicines within A06AG11

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 64470
Country: MT	Medicines Authority	Identifier(s): AA1352/00101

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.